Clinical Trial Update: A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing the bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex) to Nasacort AQ Nasal Spray (Sanofi) for seasonal allergic rhi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Nasacort AQ Nasal Spray (Triamcinolone acetonide)
• Triamcinolone Acetonide Aqueous Nasal Spray (Triamcinolone acetonide)

Snippet

Sponsor: Apotex Inc. | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED